(0.24%) 5 144.00 points
(0.14%) 38 493 points
(0.39%) 17 916 points
(-0.81%) $83.17
(-0.10%) $1.921
(0.00%) $2 347.20
(0.08%) $27.56
(2.24%) $942.75
(-0.20%) $0.933
(-0.21%) $11.00
(-0.37%) $0.797
(1.31%) $93.07
Live Chart Being Loaded With Signals
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies...
Stats | |
---|---|
本日の出来高 | 754 944 |
平均出来高 | 1.59M |
時価総額 | 40.37B |
EPS | $0 ( 2024-02-27 ) |
次の収益日 | ( $1.190 ) 2024-05-28 |
Last Dividend | $0.236 ( 2024-04-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | 33.03 |
ATR14 | $0.0610 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-25 | Binns Philip | Sell | 2 827 | Common Stock |
2024-03-15 | Wilson Dow R | Buy | 1 678 | Common Stock |
2024-03-15 | Scangos George A | Buy | 1 678 | Common Stock |
2024-03-15 | Rataj Sue H. | Buy | 1 678 | Common Stock |
2024-03-15 | Podolsky Daniel K | Buy | 410 | Common Stock |
INSIDER POWER |
---|
22.01 |
Last 98 transactions |
Buy: 528 623 | Sell: 330 144 |
ボリューム 相関
Agilent Technologies Inc 相関
10 最も負の相関 | |
---|---|
MSP | -0.926 |
RXN | -0.924 |
MOG-B | -0.923 |
IOT | -0.917 |
TDI | -0.911 |
DCT | -0.902 |
AMAM | -0.898 |
TNK | -0.897 |
KDMN | -0.892 |
AIW | -0.891 |
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Agilent Technologies Inc 相関 - 通貨/商品
Agilent Technologies Inc 財務諸表
Annual | 2023 |
収益: | $6.83B |
総利益: | $3.47B (50.71 %) |
EPS: | $4.22 |
FY | 2023 |
収益: | $6.83B |
総利益: | $3.47B (50.71 %) |
EPS: | $4.22 |
FY | 2022 |
収益: | $6.85B |
総利益: | $3.72B (54.35 %) |
EPS: | $4.19 |
FY | 2021 |
収益: | $6.32B |
総利益: | $3.41B (53.92 %) |
EPS: | $3.98 |
Financial Reports:
No articles found.
Agilent Technologies Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.210 (N/A) |
$0.435 (N/A) |
$0 (N/A) |
$0.450 (N/A) |
$0 (N/A) |
$0.461 (N/A) |
$0 (N/A) |
$0.236 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $1.471 | 2006-11-01 |
Last Dividend | $0.236 | 2024-04-01 |
Next Dividend | $0 | N/A |
Payout Date | 2024-04-24 | |
Next Payout Date | N/A | |
# dividends | 50 | -- |
Total Paid Out | $8.74 | -- |
Avg. Dividend % Per Year | 0.48% | -- |
Score | 4.72 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.20 | |
Div. Directional Score | 8.41 | -- |
Year | Amount | Yield |
---|---|---|
2006 | $1.471 | 6.14% |
2007 | $0 | 0.00% |
2008 | $0 | 0.00% |
2009 | $0 | 0.00% |
2010 | $0 | 0.00% |
2011 | $0 | 0.00% |
2012 | $0.286 | 1.10% |
2013 | $0.352 | 1.17% |
2014 | $0.283 | 0.71% |
2015 | $0.515 | 1.27% |
2016 | $0.477 | 1.17% |
2017 | $0.545 | 1.17% |
2018 | $0.611 | 0.90% |
2019 | $0.672 | 1.02% |
2020 | $0.540 | 0.63% |
2021 | $0.776 | 0.65% |
2022 | $1.065 | 0.68% |
2023 | $0.911 | 0.61% |
2024 | $0.236 | 0.17% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.184 | 1.500 | 6.33 | 9.49 | [0 - 0.5] |
returnOnAssetsTTM | 0.113 | 1.200 | 6.24 | 7.48 | [0 - 0.3] |
returnOnEquityTTM | 0.212 | 1.500 | 8.76 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.216 | -1.000 | 7.84 | -7.84 | [0 - 1] |
currentRatioTTM | 2.68 | 0.800 | 1.586 | 1.269 | [1 - 3] |
quickRatioTTM | 1.882 | 0.800 | 3.64 | 2.91 | [0.8 - 2.5] |
cashRatioTTM | 1.081 | 1.500 | 5.11 | 7.66 | [0.2 - 2] |
debtRatioTTM | 0.238 | -1.500 | 6.04 | -9.06 | [0 - 0.6] |
interestCoverageTTM | 14.39 | 1.000 | 5.78 | 5.78 | [3 - 30] |
operatingCashFlowPerShareTTM | 6.69 | 2.00 | 7.77 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.63 | 2.00 | 7.19 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.420 | -1.500 | 8.32 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.506 | 1.000 | 4.89 | 4.89 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.197 | 1.000 | 8.07 | 8.07 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.754 | 1.000 | 6.92 | 6.92 | [0.2 - 2] |
assetTurnoverTTM | 0.615 | 0.800 | 9.23 | 7.39 | [0.5 - 2] |
Total Score | 11.63 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 32.65 | 1.000 | 6.80 | 0 | [1 - 100] |
returnOnEquityTTM | 0.212 | 2.50 | 9.20 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.63 | 2.00 | 8.12 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.669 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 6.69 | 2.00 | 7.77 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.216 | 1.500 | 7.84 | -7.84 | [0 - 1] |
pegRatioTTM | -1.031 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.291 | 1.000 | 5.22 | 0 | [0.1 - 0.5] |
Total Score | 5.20 |
Agilent Technologies Inc
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。